Colibactin DNA-damage signature indicates mutational impact in colorectal cancer-Reference-Cited by-同舟云学术

Colibactin DNA-damage signature indicates mutational impact in colorectal cancer

Published:2020-06-01 Issue:7 Volume:26 Page:1063-1069
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Dziubańska-Kusibab Paulina J.,Berger Hilmar^ORCID,Battistini Federica,Bouwman Britta A. M.^ORCID,Iftekhar Amina,Katainen Riku,Cajuso Tatiana,Crosetto Nicola,Orozco Modesto,Aaltonen Lauri A.,Meyer Thomas F.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-020-0908-2.pdf

Reference75 articles.

1. Nougayrede, J. P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848–851 (2006).

2. Putze, J. et al. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect. Immun. 77, 4696–4703 (2009).

3. Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532–537 (2019).

4. Watanabe, T., Tada, M., Nagai, H., Sasaki, S. & Nakao, M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 115, 642–648 (1998).

5. Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L-tryptophan and copper interactions linked to reduced colibactin genotoxicity in pks+ Escherichia coli;mSystems;2024-09-12

2. Benefits and concerns of probiotics: an overview of the potential genotoxicity of the colibactin-producing Escherichia coli Nissle 1917 strain;Gut Microbes;2024-09-04

3. Repair of genomic interstrand crosslinks;DNA Repair;2024-09

4. Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers;Pharmacological Research;2024-09

5. Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies;The Microbe;2024-09